Eswatini vs South-East Asia (WHO region): New cases tested for RR-/MDR-TB
Eswatini
100.0%
in 2024
South-East Asia (WHO region)
91.0%
in 2024
Eswatini rank
1st
South-East Asia (WHO region) rank
1st
New cases tested for RR-/MDR-TB over time
- Eswatini
- South-East Asia (WHO region)
How they compare
Eswatini currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Eswatini's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 1 time across 15 shared years of data; in 2007 it was South-East Asia (WHO region) ahead.
Eswatini ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.2% | 0.1% | 24.1% | Eswatini |
| 2010s | 67.7% | 30.8% | 36.9% | Eswatini |
| 2020s | 100.0% | 77.8% | 22.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Eswatini or South-East Asia (WHO region)?
- Eswatini, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Eswatini and South-East Asia (WHO region)?
- 9.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and South-East Asia (WHO region)?
- 15 years are reported by both, from 2007 to 2024.
- How do Eswatini and South-East Asia (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Eswatini ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.